{
    "id": 11685,
    "fullName": "SEC31A - ALK",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SEC31A-ALK results from the fusion of SEC31A and ALK, and leads to constitutive kinase activity and growth factor-independent proliferation in culture (PMID: 20207848). SEC31A-ALK fusions have been identified in large B-cell lymphoma and lung adenocarcinoma (PMID: 20207848, PMID: 25715771).",
            "references": [
                {
                    "id": 3632,
                    "pubMedId": 20207848,
                    "title": "ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20207848"
                },
                {
                    "id": 5926,
                    "pubMedId": 25715771,
                    "title": "SEC31A-ALK Fusion Gene in Lung Adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25715771"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 22872,
        "geneSymbol": "SEC31A",
        "terms": [
            "SEC31A",
            "ABP125",
            "ABP130",
            "HSPC275",
            "HSPC334",
            "NEDSOSB",
            "SEC31L1"
        ]
    },
    "variant": "SEC31A - ALK",
    "createDate": "09/10/2015",
    "updateDate": "04/09/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 238,
                "geneSymbol": "ALK",
                "terms": [
                    "ALK",
                    "CD246",
                    "NBLST3"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 3111,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, TAE684 inhibited Alk phosphorylation, downstream signaling and proliferation in transformed cells expressing SEC31A-ALK in culture (PMID: 20207848).",
            "molecularProfile": {
                "id": 11748,
                "profileName": "SEC31A - ALK"
            },
            "therapy": {
                "id": 2386,
                "therapyName": "TAE684",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3632,
                    "pubMedId": 20207848,
                    "title": "ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20207848"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11748,
            "profileName": "SEC31A - ALK",
            "profileTreatmentApproaches": [
                {
                    "id": 7859,
                    "name": "ALK Inhibitor",
                    "profileName": "SEC31A - ALK"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}